Clinical Trials · NCT02750410
A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 159
- Start date
- Aug 2016
- Locations
- 25 sites, Japan
- Primary endpoint
- Change From Baseline in Hemoglobin A1c (HbA1c)